SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-018121
Filing Date
2021-05-04
Accepted
2021-05-04 16:31:02
Documents
1
Period of Report
2021-05-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 15156
  Complete submission text file 0000899243-21-018121.txt   17644
Mailing Address 6 HACHOSHLIM ST. HERZELIA L3 4672406
Business Address
Arkin Moshe (Reporting) CIK: 0001321178 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40366 | Film No.: 21889005

Mailing Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138 617-952-0555
Werewolf Therapeutics, Inc. (Issuer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6 HA CHOSHLIM ST. BUILDING C, 6TH FLOOR HERZLIYA L3 4672406
Business Address 6 HA CHOSHLIM ST. BUILDING C, 6TH FLOOR HERZLIYA L3 4672406 972-97883330
Arkin Bio Ventures 2 L.P. (Reporting) CIK: 0001858705 (see all company filings)

State of Incorp.: L3
Type: 4 | Act: 34 | File No.: 001-40366 | Film No.: 21889007

Mailing Address 6 HA CHOSHLIM ST. BUILDING C, 6TH FLOOR HERZLIYA L3 4672406
Business Address 6 HA CHOSHLIM ST. BUILDING C, 6TH FLOOR HERZLIYA L3 4672406 972-97883330
Arkin Bio Ventures GPGP Ltd. (Reporting) CIK: 0001858707 (see all company filings)

State of Incorp.: L3
Type: 4 | Act: 34 | File No.: 001-40366 | Film No.: 21889006